TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell Int

Author:

Jin Zhonghai,Li Hongguang,Hong Xiaofei,Ying Guangrong,Lu Xiaofeng,Zhuang Lilei,Wu Shenbao

Funder

Zhejiang science and technology project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12935-018-0701-1.pdf

Reference37 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

2. Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial–mesenchymal transition in colorectal cancer metastasis: a system review. Pathol Res Pract. 2015;211(8):557–69.

3. Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;11(11):792.

4. Hai J, Zhu CQ, Wang T, Organ SL, Shepherd FA, Tsao MS. TRIM14 is a putative tumor suppressor and regulator of innate immune response in non-small cell lung cancer. Sci Rep. 2017;7:39692.

5. Dong B, Zhang W. High levels of TRIM14 are associated with poor prognosis in hepatocellular carcinoma. Oncol Res Treat. 2018;41(3):129–34.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trim14-IκBα Signaling Regulates Chronic Inflammatory Pain in Rats and Osteoarthritis Patients;Neuroscience;2024-06

2. TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway;Carcinogenesis;2024-01-24

3. Tripartite motif family – its role in tumor progression and therapy resistance: a review;Current Opinion in Oncology;2024-01-16

4. The Role of TRIM Proteins in Vascular Disease;Current Vascular Pharmacology;2024-01

5. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape;Journal of Advanced Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3